JP2023520469A5 - - Google Patents
Info
- Publication number
- JP2023520469A5 JP2023520469A5 JP2022559934A JP2022559934A JP2023520469A5 JP 2023520469 A5 JP2023520469 A5 JP 2023520469A5 JP 2022559934 A JP2022559934 A JP 2022559934A JP 2022559934 A JP2022559934 A JP 2022559934A JP 2023520469 A5 JP2023520469 A5 JP 2023520469A5
- Authority
- JP
- Japan
- Prior art keywords
- fenebrutinib
- pharmaceutically acceptable
- acceptable salt
- subject
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005095P | 2020-04-03 | 2020-04-03 | |
| US63/005,095 | 2020-04-03 | ||
| US202063051767P | 2020-07-14 | 2020-07-14 | |
| US63/051,767 | 2020-07-14 | ||
| PCT/US2021/025301 WO2021202825A1 (en) | 2020-04-03 | 2021-04-01 | Methods of treating relapsing multiple sclerosis using an inhibitor of bruton's tyrosine kinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520469A JP2023520469A (ja) | 2023-05-17 |
| JP2023520469A5 true JP2023520469A5 (https=) | 2024-04-10 |
Family
ID=75625678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559934A Pending JP2023520469A (ja) | 2020-04-03 | 2021-04-01 | ブルトン型チロシンキナーゼの阻害剤を使用する再発性多発性硬化症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12605376B2 (https=) |
| EP (1) | EP4125906A1 (https=) |
| JP (1) | JP2023520469A (https=) |
| KR (1) | KR20220163986A (https=) |
| CN (1) | CN115916205A (https=) |
| AU (1) | AU2021249129A1 (https=) |
| BR (1) | BR112022019846A2 (https=) |
| CA (1) | CA3177390A1 (https=) |
| CL (1) | CL2022002699A1 (https=) |
| IL (1) | IL296990A (https=) |
| MX (1) | MX2022012310A (https=) |
| TW (1) | TWI907406B (https=) |
| WO (1) | WO2021202825A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021173740A1 (en) * | 2020-02-28 | 2021-09-02 | Genentech, Inc. | Methods of treating primary progressive multiple sclerosis using an inhibitor of bruton's tyrosine kinase |
| WO2022240920A1 (en) | 2021-05-14 | 2022-11-17 | Loxo Oncology, Inc. | Cocrystalline forms of a bruton's tyrosine kinase inhibitor |
| CN114028393B (zh) * | 2021-11-07 | 2023-07-18 | 天津医科大学 | 阿帕替尼在制备治疗多发性硬化症药物的用途 |
| TW202508592A (zh) * | 2023-05-16 | 2025-03-01 | 美商建南德克公司 | 使用布魯頓酪胺酸激酶之抑制劑來治療復發型多發性硬化症之方法 |
| WO2025264860A2 (en) | 2024-06-18 | 2025-12-26 | Yale University | Methods of treating post-covid airway disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111756C2 (uk) | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| KR20170033358A (ko) | 2014-08-07 | 2017-03-24 | 파마싸이클릭스 엘엘씨 | 브루톤 티로신 키나아제 저해제의 신규한 제제 |
| WO2017148837A1 (en) | 2016-02-29 | 2017-09-08 | F. Hoffmann-La Roche Ag | Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase |
| CN107043366B (zh) | 2017-04-25 | 2020-05-26 | 中国药科大学 | 4-氨基嘧啶类化合物、其制备方法及医药用途 |
| KR102635949B1 (ko) | 2017-05-18 | 2024-02-14 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 종양 치료용 약물의 제조에 있어서의 ezh2 억제제 및 btk 억제제의 조합물의 용도 |
| WO2019208805A1 (ja) * | 2018-04-27 | 2019-10-31 | 小野薬品工業株式会社 | Ｂｔｋ阻害活性を有する化合物を有効成分として含む自己免疫疾患の予防および／または治療剤 |
| EP3849559A4 (en) * | 2018-09-12 | 2022-06-01 | Denovo Biopharma LLC | COMBINATION OF ENZASTAURIN AND INHIBITORS OF BTK AND USES THEREOF |
| TW202042815A (zh) | 2019-01-22 | 2020-12-01 | 美商建南德克公司 | 使用布魯頓（bruton）酪胺酸激酶抑制劑治療類風性關節炎、慢性自發性蕁麻疹及全身性紅斑性狼瘡的方法 |
| WO2021173740A1 (en) | 2020-02-28 | 2021-09-02 | Genentech, Inc. | Methods of treating primary progressive multiple sclerosis using an inhibitor of bruton's tyrosine kinase |
-
2021
- 2021-04-01 BR BR112022019846A patent/BR112022019846A2/pt unknown
- 2021-04-01 JP JP2022559934A patent/JP2023520469A/ja active Pending
- 2021-04-01 US US17/995,259 patent/US12605376B2/en active Active
- 2021-04-01 IL IL296990A patent/IL296990A/en unknown
- 2021-04-01 CA CA3177390A patent/CA3177390A1/en active Pending
- 2021-04-01 MX MX2022012310A patent/MX2022012310A/es unknown
- 2021-04-01 AU AU2021249129A patent/AU2021249129A1/en active Pending
- 2021-04-01 TW TW110112266A patent/TWI907406B/zh active
- 2021-04-01 CN CN202180035499.8A patent/CN115916205A/zh active Pending
- 2021-04-01 EP EP21720649.9A patent/EP4125906A1/en active Pending
- 2021-04-01 KR KR1020227037384A patent/KR20220163986A/ko active Pending
- 2021-04-01 WO PCT/US2021/025301 patent/WO2021202825A1/en not_active Ceased
-
2022
- 2022-09-30 CL CL2022002699A patent/CL2022002699A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520469A5 (https=) | ||
| JP6445637B2 (ja) | うつ病および不安を予防し治療するためのタペンタドール | |
| US12090148B2 (en) | Treatment of migraine | |
| CA3161244A1 (en) | Treatment of amyotrophic lateral sclerosis | |
| EP3206682B1 (en) | Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis | |
| EP2442832B1 (en) | Compositions and methods for treatment of multiple sclerosis | |
| CN105311029A (zh) | 抗肿瘤活性的喹啉衍生物 | |
| JP2018502898A (ja) | 神経筋疾患、神経変性疾患、自己免疫疾患、発達疾患および／または代謝疾患の処置のための、脳由来神経栄養因子（ｂｄｎｆ）の誘導された発現 | |
| AU2021205465A1 (en) | Methods of treating conditions related to the S1P1 receptor | |
| TW201204360A (en) | Treatment of multiple sclerosis with MASITINIB | |
| US20220395472A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| JP2022532098A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| KR20260016515A (ko) | 초기 특발성 파킨슨병에 대한 치료 요법 | |
| JP2025513240A5 (https=) | ||
| JP7219476B2 (ja) | 腱滑膜病変を主体とした疾患の治療薬 | |
| RU2022127814A (ru) | Способы лечения рецидивирующего рассеянного склероза с применением ингибитора тирозинкиназы брутона | |
| CA3100635A1 (en) | Combinations comprising tropifexor and cenicriviroc | |
| JP2022546042A5 (https=) | ||
| KR20250160957A (ko) | 척수성 근위축증의 치료를 위한 조성물 및 방법 | |
| WO2025018279A1 (ja) | ヒト移植片対宿主病の治療薬およびその組合せ物 | |
| WO2025096942A1 (en) | Trimeprazine for use in treating pain associated with trigeminal neuralgia | |
| CN120789216A (zh) | 一种药物组合物及其应用 | |
| US20200038414A1 (en) | Methods of treating constipation using aminosterol compositions | |
| CN118215480A (zh) | 神经病症的治疗 |